Evidence map›Paper›PMID 22619325›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Knockout of the prion protein (PrP)-like Sprn gene does not produce embryonic lethality in combination with PrP(C)-deficiency.

Nathalie Daude, Serene Wohlgemuth, Rebecca Brown, Rose Pitstick, Hristina Gapeshina, Jing Yang, George A Carlson, David Westaway

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. CRISPR/Cas9 Knockout of Shell Matrix Protein 1 in the Slipper-Snail Crepidula atrasolea.Journal of experimental zoology. Part B, Molecular and developmental evolution · 2025
    Article
  3. Article
  4. Enhanced RNA-targeting CRISPR-Cas technology in zebrafish.bioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. The First Genetic Characterization of theAnimals : an open access journal from MDPI · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. CRISPR-Cas: a tool for cancer research and therapeutics.Nature reviews. Clinical oncology · 2019
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Nathalie DaudeCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, AB, Canada T6G 2M8.
Serene Wohlgemuth
Rebecca Brown
Rose Pitstick
Hristina Gapeshina
Jing Yang
George A Carlson
David Westaway
McLaughlin Research Institute · USUniversity of Alberta · CA

Funding

TRANSGENETICS OF CHIMERIC PROTEINS IN PRION REPLICATION &DISEASEP01NS041997 · NINDS · MC LAUGHLIN RESEARCH INSTITUTE · PI DEARMOND, STEPHEN J. · 2001 to 2011
$15.0M
NINDS NIH HHS NS41997NINDS NIH HHS P01 NS041997PHS HHS MOP36377
6 · The paper itself

Abstract

The Sprn gene encodes Shadoo (Sho), a glycoprotein with biochemical properties similar to the unstructured region of cellular prion protein (PrP(C)). Sho has been considered a candidate for the hypothetical π protein that supplies a PrP(C)-like function to maintain the viability of Prnp(0/0) mice lacking the PrP(C) protein. To understand these relationships more clearly we probed the cell biology of Sho and created knockout mice. Besides full-length and a "C1" C-terminal fragment, we describe a 6-kDa N-terminal Sho neuropeptide, "N1," which is present in membrane-enriched subcellular fractions of wild-type mice. Sprn null alleles were produced that delete all protein coding sequences yet spare the Mtg1 gene transcription unit that overlaps the Sprn 3' UTR; the resulting mice bred to homozygosity were viable and fertile, although Sprn(0/0) mice maintained in two genetic backgrounds weighed less than wild-type mice. Lack of Sho protein did not affect prion incubation time. Contrasting with lethality reported for knockdown of expression in Prnp(0/0) embryos using lentiviruses targeted against the Sprn 3' UTR, we established that double-knockout mice deficient in both Sho and PrP(C) are fertile and viable up to 690 d of age. Our data reduce the impetus for equating Sho with the notional π protein and are not readily reconciled with hypotheses wherein expression of PrP(C) and Sho are both required for completion of embryogenesis. Alternatively, and in accord with some reports for PrP(C), we infer that Sho's activity will prove germane to the maintenance of neuronal viability in postnatal life.

Indexed as

Analysis of VarianceAnimalsBlotting, WesternBody WeightCell FractionationCell SurvivalCrosses, GeneticEmbryonic DevelopmentFetal ViabilityGenetic VectorsGPI-Linked ProteinsMiceMice, KnockoutNerve Tissue ProteinsNeuronsNeuropeptidesGPI-Linked ProteinsNerve Tissue ProteinsNeuropeptidesPrPC ProteinsSprn protein, mouse

Identifiers

PMID22619325
PMCPMC3384183
OpenAlexW2093638076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.